ABBV Jeffrey Ryan Stewart sells $12.4M worth of shares
Apr 03, 2025, 10:31 AM
0.00%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
Jeffrey Ryan Stewart sold 58,832 shares of ABBV on 31 March at $210.54 per share, worth a total of $12.4M. They now own 86,366 ABBV shares, or a 52% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
